What’s Ahead: This Week Notable Health Care Policy Events – Monday, April 10 National Coalition on Health Care, “Medicaid Per Capita Allotments: Exploring Implications for Medicare Beneficiaries.” Additional information: http://bit.ly/2omCpNX Monday, April 10 – Tuesday, April 11 HHS Physician-Focused Payment Model Technical Advisory Committee (PTAC), “April Public Meeting.” Additional information: http://bit.ly/2oyJICU Monday, April 10 – Wednesday,… Read more »
Posts By:
ACA Repeal & Replacement Update – 4/6
ACA Repeal and Replacement Update – April 6, 2017 Top takeaways from the week: 1) Negotiations on repeal and replace continued this week, as Congress prepares for an upcoming recess back home; 2) The House Rules Committee approved an amendment to the American Health Care Act that would provide $15 billion over the next… Read more »
Health Policy Update – 4/3
What’s Ahead: This Week Hearings/Markups – Tuesday, April 4 Senate HELP Committee, “FDA User Fee Agreements: Improving Medical Product Regulation and Innovation for Patients, Part II.” House Energy & Commerce Committee, “Cybersecurity in the Health Care Sector: Strengthening Public-Private Partnerships.” House Veterans Affairs Committee, “An Assessment of Ongoing Concerns at the Veterans Crisis Line.”… Read more »
ACA Update 7
ACA Repeal and Replacement Update – March 30, 2017 Top takeaways from the week 1) House Speaker Ryan said he doesn’t want President Trump to work with Democrats on new healthcare legislation; 2) Republicans continued discussions on a way forward on ACA repeal; 3) House Energy & Commerce Chair Walden signaled support for including cost-sharing… Read more »
Health Policy Update 3-27-17
What’s Ahead: This Week Hearings/Markups Tuesday, March 28 House Energy & Commerce Committee, “Examining FDA’s Medical Device User Fee Program.” Wednesday, March 29 House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education and Related Agencies, “Budget Hearing – Department of Health and Human Services.” House Committee on Oversight & Government Reform, “Federally-Funded Cancer Research:… Read more »
Recent Comments